ММВБ 3 358 3,0%  Nasdaq 13 542 0,0%  Биткойн 35 971 -2,4%  USD/RUB 79,6292 0,7% 
РТС 1 324 2,1%  S&P500 4 350 -0,2%  Нефть 89,1 -0,7%  EUR/RUB 89,3665 0,5% 
Dow 34 168 -0,4%  FTSE100 7 470 1,3%  Золото 1 815 -0,2%  EUR/USD 1,1224 -0,2% 

Midatech Pharma PLC Registered Shs - Профиль

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. chemotherapy - improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. immunotherapy - enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.


Название Доля (%)
Jarvis Investment Management Ltd.16,18
Kong Lam15,83
Baillie Gifford UK & Bal. Fds. - British Smaller Companies Fd.7,96
Lombard Odier Asset Management (Europe) Ltd.5,97
China Medical System Holdings Ltd.5,28
Peel Hunt LLP2,56
HSBC Bank Plc (Market-Maker)2,22
Hargreaves Lansdown Stockbrokers Ltd.1,57
ISPartners Investment Solutions AG1,02
Hargreaves Lansdown Asset Management Ltd.0,71
IG Markets Ltd.0,60
Wings Establishment0,53




Добавить или редактировать инструмент